New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 13, 2013
13:09 EDTCAH, NAVBFDA approves Navidea Lymphoseek injection for use in lymphatic mapping
Navidea Biopharmaceuticals (NAVB) announced U.S. Food and Drug Administration approval of Lymphoseek Injection, a novel product indicated for use in lymphatic mapping procedures to assist in the localization of lymph nodes draining a primary tumor in patients with breast cancer or melanoma. Lymphoseek will be sold and distributed in the U.S. on an exclusive basis by Cardinal Health (CAH).
News For NAVB;CAH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 29, 2015
07:41 EDTNAVBNavidea reports data on Lymphoseek vs. Sulfur Colloid in breast cancer
Navidea Biopharmaceuticals announced that an analysis comparing sentinel lymph node biopsy procedures using Lymphoseek injection + vital blue dye to filtered sulfur colloid + VBD in breast cancer patients was published in the Annals of Surgical Oncology. Results demonstrated the following: Lymphoseek patients had significantly fewer SLNs removed per procedure; Proportionally fewer nodes were necessary to detect cancer spread; and Nodes removed using Lymphoseek held greater predictive value for diagnosing spread of breast cancer to lymph nodes. The study was published in the January print issue of the journal, Annals of Surgical Oncology.
07:23 EDTCAHCardinal Health reports Q2 Pharmaceutical revenue up 16% to $22.B
Reports Q2 Medical revenue up 4% to $2.9B.
07:02 EDTCAHCardinal Health raises FY15 non-GAAP EPS to $4.28-$4.38 from $4.10-$4.30
FY15 EPS consensus of $4.26.
07:02 EDTCAHCardinal Health reports Q2 non-GAAP EPS $1.20, consensus $1.10
Subscribe for More Information
January 28, 2015
15:38 EDTCAHNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Celgene (CELG), consensus 99c... ConocoPhillips (COP), consensus 59c... Abbott Laboratories (ABT), consensus 67c... Occidental Petroleum (OXY), consensus 68c... Colgate-Palmolive (CL), consensus 74c... Ford (F), consensus 23c... Dow Chemical (DOW), consensus 69c... Alibaba (BABA), consensus 75c... Thermo Fisher (TMO), consensus $1.94; Time Warner Cable (TWC), consensus $2.09... Phillips 66 (PSX), consensus $1.34... Alexion Pharmaceuticals (ALXN), consensus $1.29... Baxter International (BAX), consensus $1.31... Cardinal Health (CAH), consensus $1.10... Raytheon (RTN), consensus $1.08... Northrop Grumman (NOC), consensus $2.25... Viacom (VIAB), consensus $1.28... Valero Energy (VLO), consensus $1.32... Sherwin-Williams (SHW), consensus $1.38... Hershey (HSY), consensus $1.06... Mead Johnson (MJN), consensus 88c... Zimmer (ZMH), consensus $1.71... Xcel Energy (XEL), consensus 34c... Royal Caribbean (RCL), consensus 42c... Coach (COH), consensus 66c... Kate Spade (KATE), consensus 24c... Harley-Davidson (HOG), consensus 34c... Stanley Black & Decker (SWK), consensus $1.52... L-3 Communications (LLL), consensus $2.27... JetBlue (JBLU), consensus 24c.
January 26, 2015
07:05 EDTCAHNovaBay signs Avenova distribution agreement with Cardinal Health
Subscribe for More Information
January 21, 2015
07:34 EDTNAVBNavidea's Macrophage Therapeutics unit announces plan for $2.5M financing
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use